From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Avacta Seems Stuck, but if its Antibody Substitutes Really Take Off, Well, Hang onto Your Stethoscope

By Malcolm Stacey | Thursday 24 August 2017


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Hello, Share Squashers. As the usual boring summer for share shifters drags on, with hardly any exciting action on the Footsie front and most penny shares at a standstill, we all struggle to find spare value in any stocks at the moment. I’m keeping faith with most of my old faithfuls, even if some of them, like Photo-Me (PHTM) and Feedback (FDBK) seem to dither around without adding any value. This is possibly due to the time of year, as many traders are away for the school holidays. 


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

ANP

Anpario – a recovery Buy?...

Thursday »

Cat_Fixing_Lightbulb

Bearcast issue update: all should be well

 

ORCP

Oracle Power: Cynical Foul

Time left: 09:28:56